New York, NY (PRWEB) February 18, 2014
Kantar Health, a leading global healthcare consulting firm, has received ISO 20252 certification for its research methodologies. ISO 20252 is a standard set by the International Standard Organization that establishes the terms, definitions and service requirements for organizations conducting market, opinion and social research, especially when operating on internationally.
The certification applies to Kantar Health’s Marketing Insights consulting and research work in all geographies, including Europe, Asia-Pacific, North America, and the Middle East and North Africa. Receiving ISO 20252 certification is the culmination of a year-long quality initiative undertaken by Kantar Health and ensures that clients receive the benefits of a global and consistent approach toward quality.
“Securing global ISO certification for Kantar Health demonstrates how serious we are in delivering high-quality, consistent research and a unified quality standard,” said global compliance director Jessica Santos, Ph.D. “Through our global network of quality coordinators, our healthcare clients are assured that every research and consulting project we undertake is completed to the highest and most rigorous research standards.”
About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.
Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.